Suppr超能文献

粪便微生物群移植,一种传递健康长寿的工具。

Fecal microbiota transplantation, a tool to transfer healthy longevity.

作者信息

Novelle Marta G, Naranjo-Martínez Beatriz, López-Cánovas Juan L, Díaz-Ruiz Alberto

机构信息

Department of Genetics, Physiology and Microbiology (Unity of Animal Physiology), Faculty of Biology, Complutense University of Madrid (UCM), Madrid, Spain; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Spain.

Laboratory of Cellular and Molecular Gerontology, Precision Nutrition and Aging, Madrid Institute for Advanced Studies - IMDEA Food, CEI UAM+CSIC, Madrid, Spain.

出版信息

Ageing Res Rev. 2025 Jan;103:102585. doi: 10.1016/j.arr.2024.102585. Epub 2024 Nov 23.

Abstract

The complex gut microbiome influences host aging and plays an important role in the manifestation of age-related diseases. Restoring a healthy gut microbiome via Fecal Microbiota Transplantation (FMT) is receiving extensive consideration to therapeutically transfer healthy longevity. Herein, we comprehensively review the benefits of gut microbial rejuvenation - via FMT - to promote healthy aging, with few studies documenting life length properties. This review explores how preconditioning donors via standard - lifestyle and pharmacological - antiaging interventions reshape gut microbiome, with the resulting benefits being also FMT-transferable. Finally, we expose the current clinical uses of FMT in the context of aging therapy and address FMT challenges - regulatory landscape, protocol standardization, and health risks - that require refinement to effectively utilize microbiome interventions in the elderly.

摘要

复杂的肠道微生物群会影响宿主衰老,并在与年龄相关疾病的表现中发挥重要作用。通过粪便微生物群移植(FMT)恢复健康的肠道微生物群正受到广泛关注,以通过治疗性手段传递健康长寿。在此,我们全面综述了通过FMT实现肠道微生物年轻化对促进健康衰老的益处,目前很少有研究记录其对寿命的影响。本综述探讨了如何通过标准的生活方式和药理学抗衰老干预对供体进行预处理,以重塑肠道微生物群,其带来的益处也可通过FMT传递。最后,我们阐述了FMT在衰老治疗中的当前临床应用,并探讨了FMT面临的挑战——监管环境、方案标准化和健康风险——这些都需要改进,以便在老年人中有效利用微生物群干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验